Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Galena Biopharma (NASDAQ:GALE), CEL-SCI Corporation (NYSEMKT:CVM), Synthetic Biologics (NYSEMKT:SYN)

Inovio Pharmaceuticals Inc (NYSEMKT:INO)’s shares climbed 4.96% to $3.60. The company on Mar. 17 reported financial results for the fourth quarter and year ended Dec. 31, 2013. Total revenue was $1.7 million and $13.5 million for the quarter and year ended December 31, 2013, as compared to $1.1 million and $4.1 million for the same periods in 2012. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was … Continue reading Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Galena Biopharma (NASDAQ:GALE), CEL-SCI Corporation (NYSEMKT:CVM), Synthetic Biologics (NYSEMKT:SYN)

Mark DeFrance03/2003/20

Biotech Active Runners: Galena Biopharma Inc. (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD), Rexahn Pharmaceuticals (NYSEMKT:RNN), Inovio Pharmaceuticals Inc. (NYSEMKT:INO)

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of holders of Galena Biopharma, Inc. (NASDAQ:GALE) securities between November 6, 2013 and February 14, 2014. Galena Biopharma Inc. (NASDAQ:GALE) stock performance was -12.42% in last session and finished the day at $2.82. Traded volume was 17.65 million shares in … Continue reading Biotech Active Runners: Galena Biopharma Inc. (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD), Rexahn Pharmaceuticals (NYSEMKT:RNN), Inovio Pharmaceuticals Inc. (NYSEMKT:INO)

Colin Pettis03/1903/19

FB Nasdaq FB Facebook

Healthcare Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Bristol-Myers Squibb (NYSE:BMY), Johnson & Johnson (NYSE:JNJ), Galena Biopharma (NASDAQ:GALE)

Inovio Pharmaceuticals, Inc. (NYSE MKT:INO) reported financial results for the fourth quarter and year ended December 31, 2013. Inovio Pharmaceuticals Inc. (NYSEMKT:INO) stock performance was -2.29% in last session and finished the day at $3.42. Traded volume was 7.95 million shares in the last session and the average volume of the stock remained 8.89 million shares. The beta of the stock remained 3.55. Inovio Pharmaceuticals … Continue reading Healthcare Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Bristol-Myers Squibb (NYSE:BMY), Johnson & Johnson (NYSE:JNJ), Galena Biopharma (NASDAQ:GALE)

John Bellich03/1803/18

Biotech Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Geron Corporation (NASDAQ:GERN)

The iShares Biotechnology Indexhas fallen 2.46% in the last month of trading, and biotech stalwarts Celgene (NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD ) are both down over 8%. What’s most surprising is that Celgene and Gilead are expected to have strong years in terms of earnings and the development of their respective clinical pipelines. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 0.53% in last session and … Continue reading Biotech Active Stocks: Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), Inovio Pharmaceuticals Inc (NYSEMKT:INO), Geron Corporation (NASDAQ:GERN)

Mark DeFrance03/1803/21

Biotech Most Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), MannKind (NASDAQ:MNKD)

Inovio Pharmaceuticals, Inc. (AMEX:INO) entered into an office lease (the “Lease”) with a publicly owned real estate investment trust, located in Plymouth Meeting, Pennsylvania. We expect to occupy the space commencing in the third quarter of 2014. The initial term of the lease is eleven and one-half years. We intend to use the facility for office purposes. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was 3.53% … Continue reading Biotech Most Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), MannKind (NASDAQ:MNKD)

Jason Knox03/1103/11

Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), CEL-SCI (NYSEMKT:CVM), Inovio Pharmaceuticals (NYSEMKT:INO)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s shares declined 1.14% to $8.65. The company on Feb. 25 reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -2.87% in last session and finished the day at $8.13. Traded volume was 13.50million shares in the last session and the average volume … Continue reading Biotech Active Stocks: Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD), CEL-SCI (NYSEMKT:CVM), Inovio Pharmaceuticals (NYSEMKT:INO)

Jason Knox03/1003/10